Brookwood Investment Group LLC Buys New Shares in GE HealthCare Technologies Inc. $GEHC

Brookwood Investment Group LLC bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 2nd quarter, HoldingsChannel reports. The institutional investor bought 5,857 shares of the company’s stock, valued at approximately $434,000.

Other large investors have also recently bought and sold shares of the company. Bessemer Group Inc. raised its stake in GE HealthCare Technologies by 24.3% during the 1st quarter. Bessemer Group Inc. now owns 6,671 shares of the company’s stock valued at $538,000 after purchasing an additional 1,306 shares during the last quarter. Lineweaver Wealth Advisors LLC acquired a new position in GE HealthCare Technologies during the 2nd quarter valued at $592,000. Exome Asset Management LLC acquired a new position in GE HealthCare Technologies during the 1st quarter valued at $2,050,000. Bridge Creek Capital Management LLC raised its stake in GE HealthCare Technologies by 58.2% during the 2nd quarter. Bridge Creek Capital Management LLC now owns 31,852 shares of the company’s stock valued at $2,359,000 after purchasing an additional 11,719 shares during the last quarter. Finally, Czech National Bank raised its stake in GE HealthCare Technologies by 6.6% during the 2nd quarter. Czech National Bank now owns 111,923 shares of the company’s stock valued at $8,290,000 after purchasing an additional 6,889 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Up 1.3%

Shares of GE HealthCare Technologies stock opened at $79.40 on Wednesday. The stock has a market capitalization of $36.25 billion, a P/E ratio of 16.27, a price-to-earnings-growth ratio of 2.99 and a beta of 1.13. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The company has a 50-day simple moving average of $74.99 and a 200 day simple moving average of $72.80. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter last year, the company posted $1.00 EPS. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. Research analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.87%.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on GEHC. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. BTIG Research increased their price objective on shares of GE HealthCare Technologies from $87.00 to $89.00 and gave the company a “buy” rating in a research note on Monday, October 13th. Morgan Stanley set a $74.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Zacks Research cut shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Finally, Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and a consensus price target of $85.20.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.